RecruitingPhase 1 / Phase 2NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Sponsor: Institut de Recherches Internationales Servier
Houston, TX · San Antonio, TX · +19 more sites
Colorectal Cancer clinical trials in San Antonio, TX
31 recruiting colorectal cancer studies with a site in San Antonio, TX.
All trials in San Antonio, TX · All Colorectal Cancer trials
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Houston, TX · San Antonio, TX · +29 more sites
RecruitingPhase 3NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · Denison, TX · +45 more sites
RecruitingPhase 2NCT05673148
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Sponsor: Alliance for Clinical Trials in Oncology
San Antonio, TX · +187 more sites
RecruitingPhase 1NCT06004245
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Sponsor: Vividion Therapeutics, Inc.
Houston, TX · San Antonio, TX · +14 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Austin, TX · Houston, TX · Irving, TX · +15 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Dallas, TX · Edinburg, TX · Forth Worth, TX · +30 more sites
RecruitingPhase 1NCT06440005
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Sponsor: Angiex, Inc.
Houston, TX · San Antonio, TX · +5 more sites
RecruitingPhase 1NCT07321106
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Sponsor: Cartography Biosciences
San Antonio, TX · +9 more sites
RecruitingPhase 1NCT06586515
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor: Eli Lilly and Company
Houston, TX · San Antonio, TX · +23 more sites
RecruitingPhase 1 / Phase 2NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Sponsor: Marengo Therapeutics, Inc.
Houston, TX · San Antonio, TX · +11 more sites
RecruitingPhase 1NCT06910657
IDOV-Immune for Advanced Solid Tumors
Sponsor: ViroMissile, Inc.
Houston, TX · San Antonio, TX · +1 more sites
RecruitingPhase 1 / Phase 2NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Sponsor: Artios Pharma Ltd
Austin, TX · Dallas, TX · +38 more sites
RecruitingPhase 1NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Sponsor: Pfizer
Conroe, TX · Houston, TX · +10 more sites
RecruitingPhase 1NCT06657144
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Sponsor: Coherus Oncology, Inc.
Austin, TX · San Antonio, TX · +18 more sites
RecruitingPhase 2NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Sponsor: Jazz Pharmaceuticals
Amarillo, TX · Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 1NCT07300150
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Sponsor: PAQ Therapeutics, Inc.
San Antonio, TX · +3 more sites
RecruitingPhase 1 / Phase 2NCT07169734
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Sponsor: Alentis Therapeutics AG
Houston, TX · San Antonio, TX · +7 more sites
RecruitingPhase 1NCT07503808
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Sponsor: IDEAYA Biosciences
Austin, TX · Fort Worth, TX · Houston, TX · +12 more sites
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Austin, TX · Dallas, TX · Fort Worth, TX · +8 more sites
RecruitingPhase 1NCT06756035
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Sponsor: Context Therapeutics Inc.
San Antonio, TX · +7 more sites
RecruitingPhase 1NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Sponsor: Alterome Therapeutics, Inc.
Houston, TX · San Antonio, TX · +9 more sites
RecruitingPhase 1NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Dallas, TX · Houston, TX · San Antonio, TX · +13 more sites
RecruitingPhase not listedNCT04739072
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Sponsor: M.D. Anderson Cancer Center
Dallas, TX · Houston, TX · +7 more sites
RecruitingPhase 1 / Phase 2NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Sponsor: Revolution Medicines, Inc.
Austin, TX · Dallas, TX · Houston, TX · +18 more sites
RecruitingPhase 1NCT06723236
A Study of MGC028 in Participants With Advanced Solid Tumors
Sponsor: MacroGenics
San Antonio, TX · +6 more sites
RecruitingPhase 1NCT06720987
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Sponsor: Kumquat Biosciences Inc.
San Antonio, TX · +10 more sites
RecruitingPhase 1 / Phase 2NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Sponsor: Frontier Medicines Corporation
Houston, TX · Kingwood, TX · San Antonio, TX · +12 more sites
RecruitingPhase 1 / Phase 2NCT07030257
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Tasca Therapeutics
Dallas, TX · San Antonio, TX · +11 more sites
RecruitingPhase 1 / Phase 2NCT07148128
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Sponsor: Auricula Biosciences Inc.
Dallas, TX · San Antonio, TX
RecruitingPhase 1 / Phase 2NCT05784688
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
Sponsor: TiumBio Co., Ltd.
San Antonio, TX · Tyler, TX · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.